Literature DB >> 11921173

Recent trends in breast cancer incidence and mortality.

James V Lacey1, Susan S Devesa, Louise A Brinton.   

Abstract

Breast cancer accounts for one-third of cancer diagnoses and 15% of cancer deaths in U.S. women. Its 192,000 cases and 40,000 deaths in 2001 make it the most common incident cancer (excluding superficial skin cancers) and second leading cause of cancer death. Over one-half of the 300,000 breast cancer deaths worldwide in 1990 (the latest year with such data) occurred in developed countries, but annual mortality rates ranged from 27/100,000 women in northern Europe to 4/100,000 women in Asia. Incidence data are less complete, although 1988-1992 rates varied threefold: low in Asia, intermediate in South America and Eastern Europe, and high in North America and Western Europe. Migrant studies suggest that lifestyle factors largely explain these international differences. U.S. incidence rates are generally 20%-40% higher in white women than in non-white women, but are higher in young (under age 40) black women than in young white women. Incidence rates rose in the 1970s, leveled off in the 1990s, and are declining for young women. Women in some areas of the northeast U.S. have twofold higher mortality than that of other U.S. women, but reproductive and socioeconomic characteristics explain much of that difference. In the 1970s and 1980s, mortality rates held steady in developed countries but rose in developing countries. Since 1987 mortality rates fell by 25% as a result of earlier detection and improved treatment. Age-period-cohort analyses indicate that changes in recognized risk factors may affect mortality patterns. Continued analysis of international and intranational trends may reveal targets for multidisciplinary intervention and prevention efforts.

Entities:  

Mesh:

Year:  2002        PMID: 11921173     DOI: 10.1002/em.10062

Source DB:  PubMed          Journal:  Environ Mol Mutagen        ISSN: 0893-6692            Impact factor:   3.216


  36 in total

1.  An age-period-cohort analysis of cancer incidence among the oldest old, Utah 1973-2002.

Authors:  Heidi A Hanson; Ken R Smith; Antoinette M Stroup; C Janna Harrell
Journal:  Popul Stud (Camb)       Date:  2014-11-14

2.  Cost-effectiveness of clinical breast assessment-based screening in rural Egypt.

Authors:  Adel Denewer; Osama Hussein; Omar Farouk; Waleed Elnahas; Ashraf Khater; Aiman El-Saed
Journal:  World J Surg       Date:  2010-09       Impact factor: 3.352

3.  Optimized approach to decision fusion of heterogeneous data for breast cancer diagnosis.

Authors:  Jonathan L Jesneck; Loren W Nolte; Jay A Baker; Carey E Floyd; Joseph Y Lo
Journal:  Med Phys       Date:  2006-08       Impact factor: 4.071

4.  Comparison of slot scanning digital mammography system with full-field digital mammography system.

Authors:  Chao-Jen Lai; Chris C Shaw; William Geiser; Lingyun Chen; Elsa Arribas; Tanya Stephens; Paul L Davis; Geetha P Ayyar; Basak E Dogan; Victoria A Nguyen; Gary J Whitman; Wei T Yang
Journal:  Med Phys       Date:  2008-06       Impact factor: 4.071

Review 5.  Gene therapy for carcinoma of the breast.

Authors:  M A Stoff-Khalili; P Dall; D T Curiel
Journal:  Cancer Gene Ther       Date:  2006-01-06       Impact factor: 5.987

6.  Anti-estrogen resistance in breast cancer is induced by the tumor microenvironment and can be overcome by inhibiting mitochondrial function in epithelial cancer cells.

Authors:  Ubaldo E Martinez-Outschoorn; Allison Goldberg; Zhao Lin; Ying-Hui Ko; Neal Flomenberg; Chenguang Wang; Stephanos Pavlides; Richard G Pestell; Anthony Howell; Federica Sotgia; Michael P Lisanti
Journal:  Cancer Biol Ther       Date:  2011-11-15       Impact factor: 4.742

7.  Epidemiology of Breast Cancer among Bahraini Women: Data from the Bahrain Cancer Registry.

Authors:  Randah R Hamadeh; Najat M Abulfatih; Majeda A Fekri; Hala E Al-Mehza
Journal:  Sultan Qaboos Univ Med J       Date:  2014-04-07

8.  Fatty fish and fish omega-3 fatty acid intakes decrease the breast cancer risk: a case-control study.

Authors:  Jeongseon Kim; Sun-Young Lim; Aesun Shin; Mi-Kyung Sung; Jungsil Ro; Han-Sung Kang; Keun Seok Lee; Seok-Won Kim; Eun-Sook Lee
Journal:  BMC Cancer       Date:  2009-06-30       Impact factor: 4.430

9.  Relationship between CYP3A activity and breast cancer susceptibility in Chinese Han women.

Authors:  Ping Huang; Bing Zhu; Lian-Sheng Wang; Dong-Sheng Ouyang; Song-Lin Huang; Xiao-Ping Chen; Hong-Hao Zhou
Journal:  Eur J Clin Pharmacol       Date:  2003-08-22       Impact factor: 2.953

10.  Effects of zearalenone and alpha-Zearalenol in comparison with Raloxifene on T47D cells.

Authors:  Roya Khosrokhavar; Nahid Rahimifard; Shahram Shoeibi; Morteza Pirali Hamedani; Mir-Jamal Hosseini
Journal:  Toxicol Mech Methods       Date:  2009-03       Impact factor: 2.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.